Homepage
About Us
About Kybora
Leadership Team
Success Stories
Our Global Presence
Social Responsibility
Services
M&A
Licensing
Fundraising
Strategic Advisory
News Feed
Contact
English
English
中文
Homepage
About Us
About Kybora
Leadership Team
Success Stories
Our Global Presence
Social Responsibility
Services
M&A
Licensing
Fundraising
Strategic Advisory
News Feed
Contact
English
English
中文
Other Transactions
May 26, 2023
Comments are off for this post.
Read more
Other Transactions
May 26, 2023
No comments
Read more
Other Transactions
May 26, 2023
No comments
Read more
Other Transactions
May 26, 2023
No comments
Read more
Other Transactions
May 26, 2023
No comments
Read more
Other Transactions
May 26, 2023
No comments
Read more
Other Transactions
May 26, 2023
No comments
Read more
Other Transactions
May 26, 2023
No comments
Read more
Other Transactions
May 26, 2023
No comments
Read more
Other Transactions
May 26, 2023
No comments
Read more
1
2
3
…
7
Recent blog post
.
Key Biopharma Deals of 2024
Posted: 4 days ago
KYBORA Welcomes Stefan Bluemmers as Managing Director
Posted: 1 week ago
Accelerated Approval (AA) and PRV Grant: Implications of the FDA’s Updated Guidance
Posted: 2 weeks ago
Empowering Dreams through Foundation Rwanda’s KYBORA Program
Posted: 2 weeks ago
Navigating the Complexities of Priority Review Vouchers in the Context of Accelerated Approval Withdrawals
Posted: 1 month ago
Tags
.
#biopharma Licensing
Announcement
Bausch Health
biopharma
biotechnology
China
Conference
Corporate
globalhealthcare
healthtech
Kybora Team
LIcensing
March 2020
mergersandacquisitions
News
Priority List
Stada license
TYPE & ENTER:
Close
